Notably, macrophages expressing VEGF-A and tyrosine kinase with immunoglobulin and epidermal growth factor homology-2 (Tie2) have been found to play a crucial role in the recovery of tumor vasculature and tumor recurrence after doxorubicin treatment (Zhang et al., 2019). This evidence concerns the gene VEGFA and neoplasm.